Abivax (STU:2X1) Total Stockholders Equity : €40.58 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Abivax Total Stockholders Equity?

Abivax's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €40.58 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Abivax's Book Value per Share for the quarter that ended in Dec. 2024 was €0.64. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Abivax's Debt-to-Equity for the quarter that ended in Dec. 2024 was 2.40.

Abivax Total Stockholders Equity Historical Data

The historical data trend for Abivax's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abivax Total Stockholders Equity Chart

Abivax Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

17.90

25.93

7.19

196.01

40.58

Abivax Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															6.08	7.19	80.49	196.01	40.58

Abivax (STU:2X1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Abivax's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(40.584	-	0)	/	63.348
	=	0.64

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Abivax's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(43.769	+	53.592)	/	40.584
	=	2.40

Abivax Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Abivax's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abivax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abivax SA (STU:2X1) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ABVX:USA AAVXF:USA 0RA9:UK ABVX:France 2X1:Germany

Address

7-11 boulevard Haussmann, Paris, FRA, 75009

Website

https://www.abivax.com

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Abivax Headlines

No Headlines